Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.420
0.00 (0.00%)
At close: Feb 27, 2026, 4:00 PM EST
2.309
-0.111 (-4.60%)
After-hours: Feb 27, 2026, 7:46 PM EST
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $305.66 million as of February 27, 2026. Its market cap has increased by 52.14% in one year.
Market Cap
305.66M
Enterprise Value
232.27M
1-Year Change
52.14%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $305.66M, an increase of 161.17%. That is a compound annual growth rate of 21.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 305.66M | 24.10% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 325.04M |
| Aldeyra Therapeutics | 323.68M |
| Avalo Therapeutics | 322.86M |
| Cabaletta Bio | 322.49M |
| Immuneering | 322.20M |
| Protara Therapeutics | 314.56M |
| Cellectis | 299.44M |
| AC Immune | 294.85M |